(Q42164585)

English

A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: effect of selective dopamine receptor agonist fenoldopam

scientific article published on February 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: effect of selective dopamine receptor agonist fenoldopam (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

1 reference

based on heuristic

inferred from title

Sanjeev Kumar Sharma

6

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

5

object named as

David Reich

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

author name string

Annapoorna S Kini

1

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Cristina A Mitre

2

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Michael Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Mazullah Kamran

4

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

publication date

1 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Catheterization and Cardiovascular Interventions

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

169-173

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

1 reference

https://api.crossref.org/works/10.1002%2FCCD.10038

21 January 2018

Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study

1 reference

https://api.crossref.org/works/10.1002%2FCCD.10038

21 January 2018

The effects of fenoldopam, a selective dopamine receptor agonist, on systemic and renal hemodynamics in normotensive subjects

1 reference

https://api.crossref.org/works/10.1002%2FCCD.10038

21 January 2018

Selective dopamine-1 receptor agonist augments regional myocardial blood flow: comparison of fenoldopam and dopamine

1 reference

https://api.crossref.org/works/10.1002%2FCCD.10038

21 January 2018

Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality

1 reference

https://api.crossref.org/works/10.1002%2FCCD.10038

21 January 2018

A prospective randomized trial of prevention measures in patients at high risk for contrast nephropathy: results of the P.R.I.N.C.E. Study. Prevention of Radiocontrast Induced Nephropathy Clinical Evaluation

1 reference

https://api.crossref.org/works/10.1002%2FCCD.10038

21 January 2018

The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1002%2FCCD.10038

21 January 2018

Risks for renal dysfunction with cardiac angiography

1 reference

https://api.crossref.org/works/10.1002%2FCCD.10038

21 January 2018

Effects of saline, mannitol, and furosemide on acute decreases in renal function induced by radiocontrast agents

1 reference

https://api.crossref.org/works/10.1002%2FCCD.10038

21 January 2018

The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography

1 reference

https://api.crossref.org/works/10.1002%2FCCD.10038

21 January 2018

Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency

1 reference

https://api.crossref.org/works/10.1002%2FCCD.10038

21 January 2018

Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media

1 reference

https://api.crossref.org/works/10.1002%2FCCD.10038

21 January 2018

Risk of radiocontrast nephropathy in patients with and without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1002%2FCCD.10038

21 January 2018

Potential of dopamine A-1 agonists in the management of acute renal failure

1 reference

https://api.crossref.org/works/10.1002%2FCCD.10038

21 January 2018

Radiocontrast nephrotoxicity. A review.

1 reference

https://api.crossref.org/works/10.1002%2FCCD.10038

21 January 2018

Calcium-channel blockers for prophylaxis of radiocontrast-associated nephrotoxicity

1 reference

https://api.crossref.org/works/10.1002%2FCCD.10038

21 January 2018

Renal hemodynamics in radiocontrast medium-induced renal dysfunction: A role for dopamine-1 receptors

1 reference

https://api.crossref.org/works/10.1002%2FCCD.10038

21 January 2018

Identifiers

10.1002/CCD.10038

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42164585&oldid=1935060067"